Moonwalk Biosciences
Company Type: Therapeutic development
Main focus: Developing new therapeutics by targeting the epigenome
Company stage: Pre-clinical
Diseases: not disclosed
Genome-editing tool: CRISPR
Funding stage: Series A
Location: South San Francisco, California, USA
Website: https://moonwalk.bio/
Pipeline:
Partners:
Moonwalk Biosciences is the first company to couple an epigenetic discovery platform with precise engineering to develop epigenetic therapeutics. Using advanced AI-based prediction of epigenetic targets and CRISPR-based precision technology, Moonwalk Biosciences aims to develop therapies to reprogramme cells to their healthy state. Moonwalk Bioscience’s focus on epigenetic engineering allows for a read-and-write technology with the potential to treat diseases at their root cause.